thelancetsummit.com

What It Is

The Lancet Summit is an international multidisciplinary academic summit hosted by the world-leading medical journal The Lancet (part of Elsevier). The upcoming event, themed “Shaping the Future of Diabetes Prevention,” is scheduled to take place in Sitges, Spain, from November 30 to December 2, 2026. It aims to explore and define the future of diabetes prevention, research, and practice.

Core Dimensions

• Subject Area: Highly focused on the intersection of medical endocrinology and public health, especially the prevention, care, and complication management of type 1, type 2, and gestational diabetes. It also covers the widely discussed role of GLP-1 receptor agonists in diabetes prevention and management.
• Format: A fully in-person international academic conference, featuring talks by world-class experts, in-depth debates, and opportunities for attendees to present their own research through short oral presentations and posters. The abstract submission deadline is June 12, 2026.
• Faculty/Institutional Background: Extremely strong academic backing. The event is hosted by The Lancet group, with a scientific committee composed of senior editors from several of its specialty journals, such as The Lancet Diabetes & Endocrinology and The Lancet Public Health. Its advisory committee brings together leading experts from top institutions including the University of Oxford, the University of Leicester, and KU Leuven.
• Accreditation/Certificate: The text does not mention any attendance certificate or continuing education credits.

Pricing

The website does not disclose specific registration fees. However, based on the usual practice for The Lancet and other top-tier international medical summits, registration fees are typically high, and attendees are expected to cover their own international travel and accommodation costs.

Pros and Cons

• Pros: Undeniable academic authority; cutting-edge and highly relevant topics addressing the global surge in diabetes; an excellent platform for direct engagement with global thought leaders and for presenting one’s own research; broad perspective spanning clinical medicine, public health, psychology, policy, and other disciplines.
• Cons: In-person participation only, making location and scheduling demanding; an extremely specialized theme with a narrow target audience; limited transparency around pricing and online participation options.

Who It’s For

Highly suitable for endocrinologists, medical students, diabetes researchers, public health experts, nutritionists, epidemiologists, and relevant policymakers. Not suitable for the general public without a medical background or audiences looking for basic popular science content.

Access in China

Elsevier and The Lancet-related domains are generally directly accessible in mainland China, with no major network access barriers. However, actual attendance requires handling visa arrangements and international travel.